Seshadri Neervannan
Chief Operating Officer · Tarsus Pharmaceuticals, Inc.
- 2026
- Sep 9, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Seshadri Neervannan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Bobak R. Azamian - $4.69M in TARS purchases and sales in the last 12 months
- William J. Phd Link - $2.62M in TARS purchases and sales in the last 12 months
- Elizabeth Yeu Lin - $2.20M in TARS purchases and sales in the last 12 months
- Jeffrey S. Farrow - $1.32M in TARS purchases and sales in the last 12 months
- Aziz Mottiwala - $893K in TARS purchases and sales in the last 12 months
- Bryan Wahl - $850K in TARS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Seshadri Neervannan?
Seshadri Neervannan is a corporate insider, tracked as Chief Operating Officer of Tarsus Pharmaceuticals, Inc. (TARS). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Seshadri Neervannan submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Seshadri Neervannan been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($2.00M) across all tracked filings.
